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Abstract 
 
One of the causes of primary hypertension is an exposure to free radicals. The formation of free radicals in the body can 
be prevented by taking antioxidants. Zinc and copper are cofactors of endogenous antioxidant enzyme superoxide 
dismutase. This study aimed to analyze the differences of zinc and copper levels in primary hypertensive and 
normotensive patients. This was an analytical observational study with cross sectional design and simple random 
sampling method. Subjects were patients aged 40-70 years at Haji General Hospital consisting of 15 primary 
hypertensive patients and 15 normotensive individuals (comparison group). Data was collected through interviews and 
laboratory test of blood samples. Zinc and Copper serum concentrations were measured by AAS. Data were analyzed 
by chi-square and independent samples t-test. The results showed that the mean levels of zinc and copper in primary 
hypertensive patients was lower than normotensive. However, statistically there was no difference in zinc serum levels 
(p=0.852) in the two groups, and there was a significant difference in copper serum levels (p=0.032). It can be 
concluded that there were differences in copper serum levels between the two groups but not with the levels of zinc.  
 
 
Abstrak 
 
Kadar Zinc dan Cuprum pada Penderita Hipertensi Primer dan Normotensi. Salah satu pencetus hipertensi primer 
yaitu paparan radikal bebas. Pembentukan radikal bebas dalam tubuh dapat dicegah dengan antioksidan. Peran zinc dan 
cuprum adalah sebagai kofaktor dari enzim antioksidan endogen superoksida dismutase (SOD). Penelitian ini bertujuan 
untuk menganalisis perbedaan kadar serum zinc dan cuprum pada kelompok hipertensi primer dan normotensif. 
Penelitian ini merupakan penelitian observasional analitik dengan desain cross sectional dan metode simple random 
sampling. Subjek adalah orang yang berusia 40-70 tahun, mengunjungi Rumah Sakit Haji Surabaya, dan terdiri dari 15 
responden hipertensi primer dan 15 responden normotensif (kelompok pembanding). Data dikumpulkan melalui 
wawancara dan uji laboratorium klinis sampel darah. Konsentrasi serum zinc dan cuprum diukur dengan metode AAS 
(Spektrofotometer Serapan Atom). Data dianalisis dengan chi-square dan independent T-test. Hasil penelitian 
menunjukkan bahwa tingkat rata-rata serum zinc dan cuprum responden pada kelompok hipertensi primer lebih rendah 
daripada kelompok normotensif. Namun, secara statistik tidak ada perbedaan yang signifikan (p=0,852) kadar serum 
zinc antara kelompok hipertensi primer dan kelompok normotensi, tapi ada perbedaan yang signifikan pada kadar serum 
cuprum (p=0,022). Kesimpulannya adalah ada yang berbeda dari kadar serum cuprum antara dua kelompok sedangkan 
untuk kadar serum zinc tidak berbeda. 
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Introduction 
 
Hypertension problem is still prevalent among the 
people in the world and in Indonesia. Data from Global 
Burden of Disease (2010) stated that hypertension has 
become a major risk factor of cardiovascular disease.1 
Primary hypertension that is not treated immediately 
will develop into degenerative diseases. A Survey done 
by Riskesdas (2007) showed that the cause of death in 
Indonesia was dominated by degenerative disease 
including stroke (26.9%), hypertension (12.3%), 
diabetes mellitus (10.2%) and ischemic heart disease 
(9.3%). 
 
The prevalence of hypertension in Indonesia tends to 
increase. Riskesdas (2013) reported that a tendency of 
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hypertension prevalence that based on diagnoses and 
anti-hypertension drug increased from 7.6% (2007) to 
9.5% (2013). East Java was one of the provinces with 
hypertension prevalence (37.4%) higher than the 
national prevalence (31.7%). 
 
Ninety to ninety five percent of hypertension cases are 
primary hypertension and 5-10% cases are secondary 
hypertension.4 Primary hypertension is a condition in 
which there is an increase in blood pressure (above 
140/90 mmHg) in adults with at least three consecutive 
measurements, and the cause is not known for 
certain.4,5,6 Most primary hypertension occurs without 
symptoms and definitive signs. It is caused by multi 
factors, and there is an interaction between genetic and 
environmental factors.7 In addition, there are many 
behavior risk factors that can cause hypertension 
including food consumption (high in salt and fat, low in 
fiber), alcohol consumption, smoking habits, physical 
inactivity and lack of exercise, and poor stress 
management.7  
 
It has been argued that free radicals play a role as a 
trigger factor of hypertension.8 Free radicals and ROS 
(Reactive Oxygen Species) are generated from the 
oxidation reaction of complex sub cellular level. If there 
is not enough antioxidant system in the body, oxidative 
stress can occur, and it can damage critical components 
of body cells. Cell damage caused by ROS occurs due 
to damage to proteins that can intrude endogenous 
antioxidant enzyme activity, and it can cause DNA 
damage and lipid damage that affects the structure of 
cell membranes.10  
 
One of the endogenous antioxidants enzymes involved 
in the degradation process of intracellular ROS 
compounds are Superoxide Dismutase (SOD) and 
Glutathione Peroxidase (GPx).10 Zinc and copper are 
cofactors of superoxide dismutase (SOD). Zinc 
stabilizes the protein structure of the enzyme Cu-Zn-
SOD, while copper catalyzes enzyme Cu-Zn-SO.11 
 
Several previous studies related to the role of trace 
elements toward hypertension showed that zinc and 
copper deficiency is associated with decreased potential 
antioxidant.12 In addition, zinc deficiency affects 
immune cells, increases oxidative stress and 
inflammatory cytokines in which all are involved in the 
pathogenesis of primary hypertension.13 
 
Based on the problems and the importance of the role of 
zinc and copper as endogenous antioxidants in reducing 
hypertension by binding free radicals, this study was 
conducted. Hopefully, after knowing the levels of zinc 
and copper, deficiency improvement of each trace 
element can be done with adequate consumption of zinc 
and copper.   
 
Methods 
 
This is an analytic observational study that describes the 
relationship between the independent (serum zinc and 
copper levels) and dependent variables (hypertension) 
through hypothesis testing. This study used 
Comparative Cross Sectional Design. At this survey 
researchers approached or measured different samples 
while at the same time identified risk factors in the 
subjects group. This study was conducted in Haji 
General Hospital Surabaya in June-August 2014. 
Laboratory tests were carried out in the Laboratory 
Installation of Haji General Hospital Surabaya and 
Surabaya Regional Medical Laboratory. 
 
Subjects were respondents aged 40-70 years old who 
visited Haji General Hospital Surabaya. Inclusion 
criteria for the study were as follows: aged 40-70 years 
old, male and female, normal level of albumin, willing 
to follow the study and to sign the informed consent, 
willing to have blood drawn and were not taking 
supplements of zinc and copper before study. As for the 
exclusion criteria: pregnant and lactating women, 
suffering from other diseases (e.g, diabetes mellitus, 
stroke, coronary heart disease, kidney disease, 
preoperative cancer, and preoperative chronic infectious 
disease).14 The sampling technique in this study was 
simple random sampling method. Furthermore, the 
subjects were divided randomly into primary 
hypertensive groups and normotensive groups, each 
with 15 respondents. Structured interviews and blood 
sampling were also conducted for selected subjects. 
 
This study protocol was reviewed by the Ethics 
Committee of Haji General Hospital Surabaya regarding 
the protection of human rights and well-being in 
medical research. Before the data was collected, the the 
objectives, benefits, and impact of their participation in 
the study were explained to the subjects. Then, the 
subjects were asked to sign an informed consent as 
evidence of the willingness of the participants in the 
study. 
 
Respondent characteristic data were obtained through 
interviews to know their age, gender, family history of 
hypertension, smoking, exercise habits and body mass 
index. Assessment of serum levels of zinc and cuprum 
and SOD was obtained from the results of laboratory 
tests. 
 
Zinc and copper serum concentrations were measured 
by the Atomic Absorbant Spectrophotometry (AAS) 
method which was expressed in units of µmol/L. Zinc 
status was classified into normal (10-15 µmol/L) and 
deficient (if <10 µmol/L) (Gibson, 2005). Cut-off point 
for Copper serum level in a normal range was between 
8.8 to 13.5 µmol/L for men and from 10.7 to 26.6 
µmol/L for women (Gibson, 2005). While, SOD levels 
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were measured by ELISA (Enzyme Linked Immune 
Sorbent Assay). 
 
The data was analyzed with two mean difference test 
(independent samples T-test) for ratio scale data, Mann 
Whitney test for ordinal scale data, followed by Chi 
Square test to determine the prevalence ratio. 
Furthermore, to determine the relative prevalence of 
each independent variable odds ratio test was 
conducted. Normality of data distribution was tested 
with the Kolmogorov-Smirnov test. 
 
Result and Discussion 
 
The study involved 30 respondents consisting of 15 
people included in hypertensive group and 15 people in 
normotensive group. According the age, most 
hypertensive respondents were 60-70 years old (46.6%). 
The average age of the respondents in the normotensive 
group was 45.2±5.54 years with a minimum age of 40 
years and maximum age of 59 years. While in the 
hypertensive group, the average age of respondents was 
55.67±8.88 years with a minimum age of 40 years and 
maximum age 65 years. There were more male 
respondents than women in the hypertensive group with 
a mean value of systolic blood pressure of 145.67±9.04 
mmHg and diastolic blood pressure of 93.33±6.17 
mmHg (Table 1). 
 
Triggering factors of hypertension were divided into 
factors that cannot be modified and the factors that can 
be modified. Age, gender, and family history of 
hypertension were factors that cannot be modified, 
while the factors that can be modified included 
smoking, lack of exercise and body mass index (Table 
2). 
 
Relationship between Age with Hypertension. This 
study indicated that respondents aged 55 years and older 
were more common in the hypertension group (60%) 
compared to the normotensive group (13.3%). Based on 
the results of the analysis the correlation between age 
and hypertension was p<0.05. Respondents aged 55 
years and older had 9.75 greater risk for hypertension 
than respondents aged 54 years and below (Table 2). 
 
Age is a risk factor for hypertension that cannot be 
controlled. It has been argued that the incidence of 
hypertension increases with age. In old age, blood 
vessels lose elasticity. A decrease in the elasticity of the 
connective tissue and the relaxation of vascular smooth 
muscle result in decreased distension ability and tensile 
strength of the blood vessels so that the ability of the 
aorta and large arteries to accommodate the volume of 
blood pumped by the heart decreases, causing a 
decrease in cardiac output and increased peripheral 
resistance resulting in increased blood pressure.4 
 
In addition, the aging process is also associated with the 
free radical theory, which argues that fisiolofis function 
changes because of the accumulation of macromolecular 
oxidative irreversible changes due to free radicals.9 This 
accumulation increases with age so that more cell 
damage occurs, caused by oxidative stress. If this 
condition lasts for a long time, it can cause 
hypertension.18 Research conducted by Winarsih et al. 
(2013) revealed that SOD activity decreased in the 
elderly. This proves that the free radical levels increases 
with age. 
 
Relationship between Sex with Hypertension. The 
results showed no significant relationship between sex 
with hypertension (p=0.273). In the hypertensive group 
there were more male respondents (53.3%) than female 
respondents (46.7%). There were also male respondent 
(53.3%) in the hypertensive group compared with 
normotensive group (33.3%).  
 
 
 
Table 1. Distribution Characteristics of Respondents 
 
Hipertension Normotension Total Variable 
n % n % n % 
Age       
40-49 4 26.7 12 80 16 53.4 
50-59 4 26.7 3 20 7 23.3 
60-70 7 46.6 0 0 7 23.3 
Sex       
Male 8 53.3 5 33.3 13 43.3 
Female 7 46.7 10 66.7 17 56.7 
Diastolic blood pressure (mmHg) 
Sistolic 145.67±9.04 107.53±7.06   
Diastolic 93.33±6.17 71.2±4.16   
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Based on the results of the analysis, it was found that 
that gender cannot be concluded as a risk factor for 
hypertension (OR=2.286; CI 95%: from 0.522 to 
10.011; p>0.05). It was suspected that both 
respondents—both men and women—had the same 
opportunities to be exposed to various external risk 
factors such as hypertension, lifestyle shift in diet, and 
physical inactivity (Table 2). 
 
It has been argued that the incidence of hypertension is 
higher in men than women up to the age of about 55 
years. At the age between 55-74 years the risk of 
hypertension in men and women is almost the same; 
however, after the age of 74, women are at higher risk 
of developing hypertension.19 This is related to the role 
of the estrogen. Estrogen may function as an 
antioxidant. Estrogen prevents oxidation of LDL (Low 
Density Lipoprotein). LDL cholesterol is more easily 
penetrated by the plaque in the blood vessel walls when 
oxidized. Moreover, estrogen also plays a role in the 
vasodilatation of blood vessels and blood vessels 
elasticity. With reduced estrogen at menopause, women 
become vulnerable to the risk of hypertension.5 
 
Relationship between Smoking with Hypertension. 
Most respondents did not have smoking habits. Only 5 
people out of all respondents smoked, and the fifth 
respondents (33.3%) had hypertension. While in the 
normotensive group, none of the respondents had 
smoking habit. The analysis of the Fisher's Exact Test 
showed that there were significant differences in 
smoking habits (p=0.042) between the hypertensive and 
normotensive groups (Table 2).  
 
 
 
 
Table 2. Factors Associated with Hypertension 
 
Hypertension Normotension Variable 
n % n % OR (CI 95%) p 
Age     
≥ 55 9 60 2 13.3 
≤ 54 6 40 13 86.7 
Total 15 100 15 100 
9.750 (1.592-59.695) 0.014* 
 
Sex     
Male 8 53.3 5 33.3 
Female 7 46.7 10 66.7 
Total 15 100 15 100 
2.286 (0.522-10.011) 0.273 
 
History of Hypertension     
Yes, parents 10 66.7 4 26.7 
No 5 33.3 11 73.3 
Total 15 100 15 100 
5.50 (1.145-26.412) 0.033* 
 
Smoking habit     
Yes, Once 5 33.3 0 0 
Never 10 66.7 15 100 
Total 15 100 15 100 
- 
0.042** 
 
Exercise     
Yes, Often 8 53.3 13 86.7 
Never 7 46.7 2 13.3 
Total 15 100 15 100 
5.688 (0.939-34.457) 0.059 
 
BMI (Body Mass Index)     
Exceeding normal 11 73.3 1 6.70 
Normal 4 26.7 14 93.3 
Total 15 100 15 100 
38.5 (3.74-395.41) 0.002* 
 
*) Chi-Square test, significant (p<0.05) 
**) Test Fisher's Exact Test, significant (p<0.05) 
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Some previous cross-sectional studies have also found 
an association between smoking and hypertension. 
RISKESDAS 2007 showed that smoking is a risk for 
hypertension. In theory, this is likely due to the 
chemical nicotine in cigarettes and the carbon monoxide 
inhaled through cigarette smoke into the blood flow, 
which damage the endothelial of blood vessels and 
cause increased heart rate and blood pressure.19 
Exposure to cigarette smoke is a form of free radicals 
which in the long term can increase lipid peroxidation, 
triggering oxidative stress, and can damage the 
endothelial lining of blood vessels causing 
hypertension. A study by Rust (2004) proved that the 
SOD activity in smokers is lower than non-smokers.20 
 
Relationship between Family History with 
Hypertension. A family history of hypertension may 
also be a risk factor for hypertension. In this study, 
respondents who had a family history of hypertension 
from their parents were more common in hypertension 
group (66.7%) than the normotensive group (26.7%). 
The presence of family history of hypertension 
increased the risk of developing hypertension by 5.5 
times compared to no family history of hypertension 
(OR=5.5; CI95%: 1145-26412; p<0.05).   
 
Theoretically, primary hypertension is usually 
associated with genetic factors. Someone may have a 
greater chance of suffering from hypertension if parents 
have hypertension. Hypertension tends to be a 
hereditary disease, although it has not been proven with 
diagnostic tests. Duprez (2008) reported that a normal 
person with a family history of hypertension has 
decreased parasympathetic nerve activity. Changes in 
the autonomic nervous can be derived through genetic 
role in the incidence of hypertension.22 
 
Relationship between Exercise with Hypertension. 
Physical activity or exercise done regularly for 30-45 
minutes can reduce the risk of hypertension.19 Sports is 
associated with the management of hypertension 
because it can decrease the peripheral resistance of 
blood circulation that can reduce hypertension. In 
addition, exercise can also improve the elasticity of the 
endothelium of blood vessel walls by inhibiting the 
formation of free radicals and increasing the production 
of nitric oxide. Thus the formation of arteriosclerosis 
progression may be inhibited and prevent 
hypertension.23  
 
In this study, lack of exercise habits can not be 
concluded as a risk factor for hypertension (OR=5.688; 
CI 95%: 0.939-3.4457; p=0.059). This means—not in 
accordance to the theory—that respondents in this study 
who had less physical activity did not suffer from 
hypertension. 
 
Relationship between Body Mass Index with 
Hypertension. Body Mass Index (BMI) is the most 
practical method of determining the level of overweight 
and obesity in adult respondents under the age of 70 
years (WHO, 2006). In this study, BMI was classified 
according to WHO (2004): thin (<18.5 kg/m2), normal 
(18.5 to 24.9 kg/m2), overweight (≥25 kg/m2), pre- 
obesity (25 to 29.9 kg/m2), and obese (≥30 kg/m2). 
 
The results showed, the average value BMI in 
hypertensive group was 26.43±3.52 kg/m2 higher when 
compared to the normotensive group 23.71±1.36 kg/m2. 
Based on the analysis, we found a significant 
relationship (p<α) between BMI with hypertension. 
Respondents with BMI more than normal (overweight 
or obese) had a 38.5 higher risk of developing 
hypertension compared with respondents who had a 
normal BMI (Table 2). 
 
A previous study (Bay et al, 2007), which compared 
data from SHIELD and NHANES, also stated that the 
increase in BMI is generally associated with the 
prevalence of hypertension (p<0.001). There were as 
many as 46-55% of hypertensive patients who were 
obese, and 80-85% were overweight.20 In theory, 
obesity that is followed by increasing fat metabolism 
will lead to increased production of ROS (Reactive 
Oxygen Species) in circulation and in adipose cells. 
ROS can stimulate inflammation and induce cell 
apoptosis. Increased ROS in adipose cells leads to the 
disruption of the balance of oxidation-reduction 
reactions, resulting in a decrease in antioxidant enzyme 
in the circulation. This situation is called oxidative 
stress. Oxidative stress is believed to have an important 
role in the pathophysiology of hypertension.24 
 
Thus, it can be argued that another factor that causes 
hypertension is the presence of free radical exposure. 
Free radicals can be resisted by antioxidants. The body 
has natural antioxidant enzymes such as superoxide 
dismutase (SOD). This enzyme is catalyzed by zinc and 
copper. The difference between the levels of zinc, 
copper and SOD in hypertensive and normotensive 
groups can be seen in Table 3. 
 
Relationship between Zinc with Hypertension. Zinc 
is an essential component in the structure and function 
of the cell membrane. Zinc functions as an antioxidant 
and protects the body against lipid peroxidation. Zinc is 
needed for enzyme superoxide dismutase (SOD) 
activity. SOD disables superoxide anion and peroxides 
that are free radicals. Copper and zinc induce 
superoxide dismutase (SOD) to clean up free radicals.12  
 
In this study, the mean serum level of zinc in the 
hypertension group (9.96±2.88 mol/L) was lower than 
the normotensive group (10.9±5.08 mol/L). 
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Table 3.  Distribution of Zinc, Copper, and Superoxide Dismutase Concentrations on Participants 
in Hypertensive and Normotensive 
 
Variable Mean SD p value 
Concentration of zinc (µmol/L) 
Hypertensive 9.96 2.88 
Normotensive 10.9 5.08 
0.852 
 
Concentration of Copper (µmol/L) 
Hypertensive 41.37 18.39 
Normotensive 58.47 22.03 
0.022* 
 
Concentration of SOD (U/mL) 
Hypertensive 0.82 0.56 
Normotensive 1.27 0.62 
0.177 
 
 
Table 4. Distribution of the Status of Zinc and Copper on Participants 
 
Hypertension Normotension Variable 
n % n % PR (CI 95%) p 
Zinc Status 
Deficiency (< 10 µmol/L) 10 66.7 7 46.7 
Normal (10-15 µmol/L) 5 33.3 8 53.3 
2.286 
(0.522-10.011) 
0.273 
Copper Status 
Deficiency (< 8.8 µmol/L) 11 73.3 8 53.3 
Normal (8.8-17.5 µmol/L) 4 26.7 7 46.7 
2.406 
(0.521-11.104) 
0.260 
 
 
Serum zinc level of the hypertensive group was in the 
category of zinc deficiency (less than 10 mol/L). The 
normal value of serum zinc level is 10-15 mol/L.15 This 
research found the same results as study done by 
Chiplonkar et al, (2004), which reported that the 
erythrocyte zinc level in hypertensive patients was 
lower than the normotensive.15 However, the results of 
this study showed that there was no significant 
statistical association between zinc status (OR=2.286; 
95% CI: 0522-10011; p>0.05) and the incidence of 
hypertension (Table 4). 
 
It can be argued, therefore, that zinc is associated with 
the incidence of hypertension through the pathogenesis 
of atherosclerosis, including vascular endothelial 
dysfunction and inflammatory response. Reiterer et al. 
(2005) found an increase in LDL cholesterol and 
oxidative stress in rats with zinc deficiency. Prolonged 
oxidative stress can cause inflammation that contributes 
to atherosclerosis. In addition, zinc deficiency can 
reduce the function of Cu-Zn SOD enzymes that act as 
antioxidants. Zinc catalyzes the superoxide dismutase 
reaction. A decrease in the activity of this enzyme 
triggers excessive formation of free radicals, which in 
turn can damage the endothelium relaxation factor in the 
blood vessels. 
 
Relationship Copper with Hypertension. The mean 
level of copper serum in hypertensive group (5.99±2.96 
mol/L) was also lower than the normotensive group 
(8.78±3.30 mol/L). Copper serum level of the 
hypertensive group in the category of deficiency copper 
was 8.8-13.5 mol/L for men and 10.7-26.6 µmol/L for 
woman. This was reinforced by the results of the 
statistical analysis of Independent T-test which showed 
that a mean difference of copper serum level was 
significant (p<0.05) between hypertensive group and 
normotensive group. Taneja (2007) also reported that 
copper serum level decreased in hypertension. However, 
the existence of such differences did not show a 
significant relationship between cuprum status 
(OR=2.406; 95% CI: 0.521-1.1104; p>0.05) and the 
incidence of hypertension. 
 
In theory, copper deficiency is associated with vascular 
defects such as aneurysms, heart enlargement and heart 
failure. Copper deficiency relative to the zinc result in 
decreased HDL (High Density Lipoprotein) and 
increased LDL (Low Density Lipoprotein) can cause 
atherosclerosis and causes hypertension.12 
 
Relationship between Superoxide Dismutase with 
Hypertension. This study showed that the average level 
of superoxide dismutase in hypertensive group (0.82± 
0.56 U/mL) was lower than the normotensive group 
(1.27±0.62 U/mL). However, the Independent T-test 
showed that there was no significant difference (p>0.05) 
of the mean level of superoxide dismutase between the 
normotensive and hypertensive groups (Tabel 3). 
 
The superoxide dismutase enzyme is a primary 
antioxidant in the body that prevents the formation of 
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new free radicals by transforming free radicals into a 
molecule that decreases the negative effects before they 
could react. The role of zinc and copper as cofactors of 
superoxide dismutase (SOD) enzyme is to scavenge free 
radicals. Zinc and copper deficiency is associated with 
the activation of SOD. In this study, deficient zinc and 
cuprum was found in each group, both hypertensive or 
normotensive respondents. Although the amount of zinc 
and cuprum deficiency was worse in patients with 
hypertension but it was not statistically significant. 
Nevertheless, the presence of zinc deficiency and 
cuprum was also followed by superoxide dismutase 
which also tended to be deficient in patients with 
hypertension. According to Bertinato (2003), decreased 
levels of zinc and copper resulted in a decrease in the 
activity of superoxide dismutase. 
 
It can be argued that the level of Superoxide dismutase 
activity in humans is more or less the same. What is 
different is capacity induction of superoxide dismutase, 
the body's ability to increase the amount of superoxide 
dismutase when it should respond to the rising number 
of oxygen radicals in the body. The older the person, 
more down superoxide dismutase activity occur. 
Besides, genetics also control superoxide dismutase. 
 
Conclusions  
 
There is no significant relationship between zinc and 
copper deficiency status with hypertension. 
Nonetheless, the average value of the concentration of 
zinc and copper serum in the hypertensive group was 
lower than the normotensive group. Superoxide 
dismutase level was lower in hypertension group. This 
study highlights the importance of endogenous 
antioxidants such as zinc and copper micro-minerals. 
Therefore, hypertensive patients should pay attention to 
the fulfillment of the nutritional needs with antioxidants 
to prevent free radicals. Frequent consumption of food 
sources of zinc and copper is essential to fulfill the 
needs of the micro-minerals in blood and to prevent 
hypertension. 
 
References 
 
1. Murray CJL, Lopez AD. Measuring the global burden of 
disease. The New England J. Med. 2013;369:448-457. 
2. Balitbangkes. Laporan Nasional Riset Kesehatan Dasar 
(RISKESDAS) Tahun 2007. Jakarta: Badan Penelitian 
dan Pengembangan Kesehatan, Departemen Kesehatan 
RI; 2008. p. 384. 
3. Balitbangkes. Riset kesehatan dasar tahun 2013. 
Jakarta: Badan Penelitian Dan Pengembangan 
Kesehatan Kementerian Kesehatan RI; 2013. p. 306. 
4. Guyton, Hall. Buku ajar fisiologi kedokteran edisi 
keduabelas. Singapore: Saunder Elsevier; 2014. p. 1172. 
[In Indonesia]. 
5. Ganong WF. Penyakit Kardiovaskular: Penyakit 
Vaskular. In: Ganong WF, McPhee SJ, editor. 
Patofisiologi Penyakit: Pengantar Menuju Kedokteran 
Klinis Edisi 5. Jakarta: EGC; 2010. p. 836. 
6. Kaplan NM. Kaplan's Clinical Hypertension Eighth 
Edition. Philadelphia, USA: Lippincott Williams & 
Wilkins; 2002. p. 314. 
7. WHO. A Global Brief on Hypertension Silent killer, 
global public health crisis. Geneva: World Health 
Organization; 2013. 
8. Carpenter WE, Lam D, Toney GM, Weintraub NL, Qin 
Z. Zinc, copper, and blood pressure: human population 
studies. Med Sci Monit. 2013;19:1-8. 
9. Muchtadi D. Antioksidan dan kiat sehat di usia produktif. 
Bandung: Alfabeta; 2013. p.208. 
10. Winarsi H. Antioksidan alami dan radikal bebas: potensi 
dan aplikasinya dalam kesehatan. Yogyakarta: Kanisius; 
2007. p. 278. 
11. Beattie JH, Kwun IS. Is zinc deficiency a risk factor for 
atherosclerosis? Br J Nutr. 2004;91(2):177-181. 
12. S.K Roy, K. Jahan. (2013). Disease Burden due to Trace 
Elements Deficiency. J Trace Elem Med Biol. 2013; 
13. Linder MC. (2010). Nutrisi dan Metabolisme 
Mikromineral. In: Linder Mc, editor. Biokimia Nutrisi 
dan Metabolisme. Jakarta: UI-Press; 2010. pp. 279-309. 
14. Gibson RS. Principles of nutritional assessment second 
edition. New York: Oxford University Press; 2005. 
p.928. 
15. Rahajeng E, Tuminah S. Prevalensi hipertensi dan 
determinannya di Indonesia. Majalah Kedokteran 
Indonesia, 2009;59(12):580-587. 
16. Winarsi H, Yuniati A., Purwanto A. Deteksi aging pada 
perempuan berdasarkan status antioksidan. Majalah 
Kedokteran Bandung. 2013;45(3):141-146. 
17. Sigarlaki HJ. Karakteristik dan faktor berhubungan 
dengan hipertensi di Desa Bocor, Kecamatan Bulus 
Pesantren, Kabupaten Kebumen, Jawa Tengah. Jurnal 
Makara Kesehatan, 2006;10(2):78-88. 
18. Duprez DA, De Sutter JH, De Buyzere ML, Rietzschel 
ER, Rimbaut S, Kaufman JM, Van Hoecke MJ, Clement 
DL. Renin-angiotensin aldosterone system, RR interval, 
and blood pressure variability during postural changes in 
borderline arterial hypertension. In: Duprez DA, editor. 
Cardiac Autonomic Imbalance in Pre-Hypertension and 
in a family history of hypertension. J Am Coll Cardiol. 
2008;51(19):1902-1903.  
19. Choudhury A, Lip GYH. Exercise and hypertension. J 
Hum Hypertens. 2005;19:585-587. 
20. Bays HE, Chapman RH, Grandy S. (2007). The 
relationship of body mass index to diabetes mellitus, 
hypertension and dyslipidemia: comparison of data from 
two national surveys. Int J Clin Pract. 2007;61(5):737-
747. 
21. Lilyasari O. Hipertensi dengan obesitas: adakah peran 
Endotelin-1? Jurnal Kardiologi Indonesia. 2007;28(6): 
460-475. 
22. Ballentine R. Diet & Nutrition A Holistic Approach. 
USA: Himalayan Institute Press; 2010. 
23. Dharmeizar. Hipertensi. Medicinus. 2012;25(1):3-8. 
24. Chehab O, Ouertani M, Souiden Y, Chaieb K., 
Mahdouani, K. Plasma antioxidants and human aging: a 
study on healthy elderly Tunisian population. Mol 
Biotechnol. 2008;40(1):27-37. 
25. Ardhie AM. Radikal Bebas dan Peran Antioksidan dalam 
Mencegah Penuaan. MEDICINUS. 2011;24(1):4-9. 
Suryana, et al. 
Makara J. Health Res.  August 2015 | Vol. 19 | No. 2 
74 
26. Taneja SK., Mandal R. Mineral factors controlling 
essential hypertension a study in the chandigarh, india 
population. Biol Trace Elem Res.2007;120(1-3):61-73. 
27. Bertinato J, Iskandar M, L’Abbe MR Copper deficiency 
induces the upregulation of the copper chaperon for 
Cu/Zn superoxide dismutase in weanling male rats. J 
Nutr. 2003;133(1):28-31. 
28. Schlenker ED. Minerals. In: Schlenker E, . Roth SL, 
editor. Williams' Essentials of Nutrition and Diet Therapy 
10th Edition. USA: Elsevier Mosby; 2011. p.656. 
29. U.S Department of Health and Human Services. The 
Seventh report of the joint national committee on 
prevention, detection, evaluation, and treatment of high 
blood pressure. United States: NH Publication; 2004. p. 
104. 
30. Reiterer G, Mc. Donald R, Browning JD, Morrow J, 
Matveev SV, Daugherty A, Smart E, Toborek M, Hennig 
B. Zinc deficiency increases plasma lipids and 
atherosclerotic markers in ldl receptor deficient mice. J. 
Nutr. 2005;135(9):2114-2118. 
 
 
 
